Cover Image
Market Research Report

Global DEXA Equipment Market - Trends and Forecast to 2024

Published by Data Bridge Market Research Private Limited Product code 536499
Published Content info 172 Pages; 163 Tables; 16 Figures
Delivery time: 1-2 business days
Price
Back to Top
Global DEXA Equipment Market - Trends and Forecast to 2024
Published: April 1, 2017 Content info: 172 Pages; 163 Tables; 16 Figures
Description

Synopsis:

Global Dual Emission X-Ray Absorptiometry (DEXA) Equipment Market is expected to reach USD 370.3 million by 2024, at a CAGR 7.1% during the forecast period of 2017 to 2024. The report contains 162 pages of exclusive premium insights with 174 tables and 25 figures.

The global DEXA market has been segmented On the basis of product type into central DEXA (C-DEXA) and peripheral DEXA (p-DEXA).

Based on application the market is segmented into bone densitometry, body composition analysis, fracture risk assessment and fracture diagnosis.

On the basis of end-user the market is segmented into hospitals, clinics and mobile health centers.

Based on geography the market is segmented into 5 geographical regions, North America, Europe, APAC, South America and MEA. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.

Major Players Operating in this market:

EMD-Millipore, Avantor Performance Materials, Tedia Company, Inc., Regis Technologies, Inc., Thermo Fisher Scientific, Inc., VWR International, and Qualikems Fine Chem Pvt. Ltd. among others.

Regions Covered In The Scope Of The Report:

Global (North America (U.S., Canada, Mexico), Europe (Germany, France, U.K., Italy, Spain, Russia, Belgium, Netherlands, Switzerland, Turkey, Rest of Europe), Asia-Pacific (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of APAC), South America (Brazil, Rest of South America), Middle East and Africa (South Africa, Rest of MEA))

Table of Contents

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OVERVIEW OF THE DEXA EQUIPMENT MARKET
  • 1.2. MARKET SEGMENTATION & COVERAGE
    • 1.2.1. CURRENCY AND PRICING
    • 1.2.2. LIMITATION
    • 1.2.3. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. KEY TAKEAWAYS
  • 2.2. ARRIVING AT THE GLOBAL DEXA EQUIPMENT MARKET
    • 2.2.1. MARKET CRACKDOWN APPROACH
    • 2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
    • 2.2.3. DATA TRIANGULATION
    • 2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
    • 2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
    • 2.2.6. EPIDEMIOLOGY DATA FORECASTING MODEL
  • 2.3. GLOBAL DEXA EQUIPMENT MARKET: RESEARCH SNAPSHOT
  • 2.4. ASSUMPTIONS

3. MARKET LANDSCAPE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. OVERVIEW
  • 4.2. GLOBAL DEXA EQUIPMENT MARKET: KEY PRIMARY INSIGHTS
  • 4.3. MARKET OVERVIEW
    • 4.3.1. DRIVERS
    • 4.3.2. RESTRAINTS
    • 4.3.3. OPPURTUNITIES
    • 4.3.4. THREATS
  • 4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5. DEXA EQUIPMENT MARKET, EPIDEMIOLOGY STUDIES

  • 5.1. OVERVIEW
  • 5.2. PREVALENT POPULATION OF OSTEOPOROSIS: MEN VS WOMEN; (2010 - 2025)
    • 5.2.1. NORTH AMERICA, BY COUNTRY
    • 5.2.2. EUROPE, BY COUNTRY
    • 5.2.3. ASIA-PACIFIC, BY COUNTRY
    • 5.2.4. REST OF THE WORLD, BY COUNTRY
    • 5.2.5. SOURCES BIBLIOGRAPHY
  • 5.3. PREVALENT POPULATION OF DIAGNOSED OSTEOPOROSIS: MEN VS WOMEN; (2010 - 2025)
    • 5.3.1. NORTH AMERICA, BY COUNTRY
    • 5.3.2. EUROPE, BY COUNTRY
    • 5.3.3. ASIA-PACIFIC, BY COUNTRY
    • 5.3.4. REST OF THE WORLD, BY COUNTRY
    • 5.3.5. SOURCES BIBLIOGRAPHY
  • 5.4. INCIDENCE OF VERTEBRAL FRACTURES: MEN VS WOMEN; (2010 - 2025)
    • 5.4.1. NORTH AMERICA, BY COUNTRY
    • 5.4.2. EUROPE, BY COUNTRY
    • 5.4.3. ASIA-PACIFIC, BY COUNTRY
    • 5.4.4. REST OF THE WORLD, BY COUNTRY
    • 5.4.5. SOURCES BIBLIOGRAPHY
  • 5.5. INCIDENCE OF HIP FRACTURES: MEN VS WOMEN; (2010 - 2025)
    • 5.5.1. NORTH AMERICA, BY COUNTRY
    • 5.5.2. EUROPE, BY COUNTRY
    • 5.5.3. ASIA-PACIFIC, BY COUNTRY
    • 5.5.4. REST OF THE WORLD, BY COUNTRY
    • 5.5.5. SOURCES BIBLIOGRAPHY
  • 5.6. PREVALENCE OF OBESITY; (2010 - 2025)
    • 5.6.1. NORTH AMERICA, BY COUNTRY
    • 5.6.2. EUROPE, BY COUNTRY
    • 5.6.3. ASIA-PACIFIC, BY COUNTRY
    • 5.6.4. REST OF THE WORLD, BY COUNTRY
    • 5.6.5. SOURCES BIBLIOGRAPHY
  • 5.7. PREVALENCE OF AORTIC CALCIFICATION; (2010 - 2025)
    • 5.7.1. NORTH AMERICA, BY COUNTRY
    • 5.7.2. EUROPE, BY COUNTRY
    • 5.7.3. SOURCES BIBLIOGRAPHY

6. DEXA EQUIPMENT MARKET, BY COMPETITIVE MARKET ASSESMENT

  • 6.1. OVERVIEW
  • 6.2. BONE DENSITOMETRY: QUANTITATIVE ct VS DEXA
  • 6.3. BONE DENSITOMETRY: QUANTITATIVE ULTRASOUND VS DEXA
  • 6.4. BODY COMPOSITION ANALYZERS: BODY IMPEDANCE ANALYZERS VS DEXA
  • 6.5. BODY COMPOSITION ANALYZERS: HYDROSTATIC WEIGHING VS DEXA

7. DEXA EQUIPMENT MARKET, BY PRODUCT TYPE

  • 7.1. OVERVIEW
  • 7.2. CENTRAL DEXA BONE DENSITOMETER (2014 - 2022)
    • 7.2.1. MARKET VALUE (USD MILLION)
    • 7.2.1. MARKET VOLUME (UNITS SOLD)
  • 7.3. PERIPHERAL DEXA BONE DENSITOMETER (2014 - 2022)
    • 7.3.1. MARKET VALUE (USD MILLION)
    • 7.3.1. MARKET VOLUME (UNITS SOLD)

8. DEXA EQUIPMENT MARKET, BY APPLICATION

  • 8.1. OVERVIEW
  • 8.2. BODY COMPOSITION ANALYSIS (2014 - 2022)
  • 8.3. BONE DENSITOMETRY (2014 - 2022)
  • 8.4. FRACTURE DIAGNOSIS (2014 - 2022)
  • 8.5. FRACTURE RISK ASSESMENT (2014 - 2022)

9. DEXA EQUIPMENT MARKET, BY END-USER

  • 9.1. OVERVIEW
  • 9.2. HOSPITALS (2014 - 2022)
  • 9.3. CLINICS (2014 - 2022)
  • 9.4. MOBILE HEALTH CENTERS (2014 - 2022)
  • 9.5. OVER THE COUNTER (2014 - 2022)

10. DEXA EQUIPMENT MARKET, BY GEOGRAPHY

  • 10.1. COUNTRYWISE DUAL EMISSION X-RAY ABSORPTIOMETRY EQUIPMENT MARKET, (2014 - 2022)
    • (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
    • (MARKET VALUE (USD MILLION), MARKET VOLUME (UNITS SOLD), AVERAGE SELLING PRICE USD))
    • 10.1.1. NORTH AMERICA
      • 10.1.1.1. U.S.
      • 10.1.1.2. CANADA
      • 10.1.1.3. MEXICO
    • 10.1.2. EUROPE
      • 10.1.2.1. GERMANY
      • 10.1.2.2. FRANCE
      • 10.1.2.3. U.K.
      • 10.1.2.4. ITALY
      • 10.1.2.5. SPAIN
      • 10.1.2.6. RUSSIA
      • 10.1.2.7. TURKEY
      • 10.1.2.8. BELGIUM
      • 10.1.2.9. NETHERLANDS
      • 10.1.2.10. SWITZERLAND
      • 10.1.2.11. REST OF EUROPE
    • 10.1.3. ASIA-PACIFIC (APAC)
      • 10.1.3.1. JAPAN
      • 10.1.3.2. CHINA
      • 10.1.3.3. SOUTH KOREA
      • 10.1.3.4. INDIA
      • 10.1.3.5. AUSTRALIA
      • 10.1.3.6. SINGAPORE
      • 10.1.3.7. THAILAND
      • 10.1.3.8. MALAYSIA
      • 10.1.3.9. INDONESIA
      • 10.1.3.10. PHILIPPINES
      • 10.1.3.11. REST OF APAC
    • 10.1.4. SOUTH AMERICA
      • 10.1.4.1. BRAZIL
      • 10.1.4.2. REST OF SOUTH AMERICA
    • 10.1.5. MIDDLE EAST AND AFRICA (MEA)
      • 10.1.5.1. SOUTH AFRICA
      • 10.1.5.2. SAUDI ARABIA
      • 10.1.5.3. UNITED ARAB EMIRATES (U.A.E)
      • 10.1.5.4. REST OF MEA
  • 10.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

11. DEXA EQUIPMENT MARKET: COMPETITIVE LANDSCAPE

  • 11.1. GLOBAL DEXA EQUIPMENT MARKET: COMPANY SHARE ANALYSIS
  • 11.2. U.S. DEXA EQUIPMENT MARKET: COMPANY SHARE ANALYSIS
  • 11.3. EUROPE DEXA EQUIPMENT MARKET: COMPANY SHARE ANALYSIS
  • 11.4. ASIA-PACIFIC DEXA EQUIPMENT MARKET: COMPANY SHARE ANALYSIS
  • 11.5. SOUTH AMERICA DEXA EQUIPMENT MARKET: COMPANY SHARE ANALYSIS
  • 11.6. MERGERS & ACQUISITIONS
  • 11.7. NEW PRODUCT DEVELOPMENT & APPROVALS
  • 11.8. REGULATORY CHANGES

12. DEXA EQUIPMENT MARKET, COMPANY PROFILES

  • 12.1. HOLOGIC, INC.
    • 12.1.1. OVERVIEW
    • 12.1.2. SWOT ANALYSIS
    • 12.1.3. PRODUCT PORTFOLIO
    • 12.1.4. REVENUE ANALYSIS
    • 12.1.5. ANALYSTS VIEW
  • 12.2. GE HEALTHCARE
    • 12.2.1. OVERVIEW
    • 12.2.2. SWOT ANALYSIS
    • 12.2.3. PRODUCT PORTFOLIO
    • 12.2.4. REVENUE ANALYSIS
    • 12.2.5. ANALYSTS VIEW
  • 12.3. OSTEOMETER MEDITECH INC.
    • 12.3.1. OVERVIEW
    • 12.3.2. SWOT ANALYSIS
    • 12.3.3. PRODUCT PORTFOLIO
    • 12.3.4. REVENUE ANALYSIS
    • 12.3.5. ANALYST VIEW
  • 12.4. SWISSRAY INTERNATIONAL, INC.
    • 12.4.1. OVERVIEW
    • 12.4.2. SWOT ANALYSIS
    • 12.4.3. PRODUCT PORTFOLIO
    • 12.4.4. REVENUE ANALYSIS
    • 12.4.5. ANALYSTS VIEW
  • 12.5. MB TECH
    • 12.5.1. OVERVIEW
    • 12.5.2. SWOT ANALYSIS
    • 12.5.3. PRODUCT PORTFOLIO
    • 12.5.4. REVENUE ANALYSIS
    • 12.5.5. ANALYSTS VIEW
  • 12.6. DMS IMAGING
    • 12.6.1. OVERVIEW
    • 12.6.2. SWOT ANALYSIS
    • 12.6.3. PRODUCT PORTFOLIO
    • 12.6.4. REVENUE ANALYSIS
    • 12.6.5. ANALYSTS VIEW
  • 12.7. THE ACN SRL
    • 12.7.1. OVERVIEW
    • 12.7.2. SWOT ANALYSIS
    • 12.7.3. PRODUCT PORTFOLIO
    • 12.7.4. REVENUE ANALYSIS
    • 12.7.5. ANALYSTS VIEW
  • 12.8. DEMETECH AB
    • 12.8.1. OVERVIEW
    • 12.8.2. SWOT ANALYSIS
    • 12.8.3. PRODUCT PORTFOLIO
    • 12.8.4. REVENUE ANALYSIS
    • 12.8.5. ANALYSTS VIEW
  • 12.9. AMPALL CO.,LTD.
    • 12.9.1. OVERVIEW
    • 12.9.2. SWOT ANALYSIS
    • 12.9.3. PRODUCT PORTFOLIO
    • 12.9.4. REVENUE ANALYSIS
    • 12.9.5. ANALYSTS VIEW

13. APPENDIX

14. ABOUT DATA BRIDGE MARKET RESEARCH

Back to Top